Skip to content

Study · Non-randomized trial · 1993

2 results

[Cerebrolysin electrophoresis in the correction of the mental defects in neurosurgery patients].

Naĭdin VL, Krotkova OA

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko1 Oct 1993

PMID8296505 (opens in a new tab)PepBankPUB-08296505
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In neurosurgery patients, electrophoretic and intravenous Cerebrolysin administration showed the same therapeutic effect.

    In plain wordsIn neurosurgery patients, electrophoretic and intravenous Cerebrolysin had the same therapeutic effect.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedTherapeutic effect by administration route
    Study

    n: not reported in source

    Comparator
    Intravenous Cerebrolysin
    Outcome group
    Overall treatment effect · Nervous system and cognition
    Studied dose
    Dose not stated · electrophoretic administrationAs given in this study (human).

    Source sentences

    Summary
    The findings indicate that these routes of administration show the same therapeutical effect, the latter route of administration is simpler and causes no pain in patients.
    2 context sentences
    Title · context
    [Cerebrolysin electrophoresis in the correction of the mental defects in neurosurgery patients].
    Summary · context
    Two routes of cerebrolysin administration--intravenous (a routine mode) and electrophoretic (the mode developed at the N. N. Burdenko Institute of Neurosurgery, Russian Academy of Medical Sciences)--were evaluated by using a standardized rating schedule of neurological and neuropsychological studies.
  2. 02HumanNon-randomized trialSafety outcome

    In neurosurgery patients, electrophoretic Cerebrolysin administration caused no pain.

    In plain wordsIn neurosurgery patients, electrophoretic Cerebrolysin administration caused no pain.

    Peptide
    Cerebrolysin
    Outcome
    Not applicablePain with electrophoretic administration
    Study

    n: not reported in source

    Outcome group
    Pain · Nervous system and cognition
    Studied dose
    Dose not stated · electrophoretic administrationAs given in this study (human).

    Source sentences

    Summary
    The findings indicate that these routes of administration show the same therapeutical effect, the latter route of administration is simpler and causes no pain in patients.
    2 context sentences
    Title · context
    [Cerebrolysin electrophoresis in the correction of the mental defects in neurosurgery patients].
    Summary · context
    Two routes of cerebrolysin administration--intravenous (a routine mode) and electrophoretic (the mode developed at the N. N. Burdenko Institute of Neurosurgery, Russian Academy of Medical Sciences)--were evaluated by using a standardized rating schedule of neurological and neuropsychological studies.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.